[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Competitor Analysis: C5a-R Antagonists

October 2010 | 14 pages | ID: CDADEF67F8CEN
La Merie Publishing

US$ 173.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Product description

The present Competitive Intelligence Report about Complement C5a & C5a Receptor Antagonists provides a competitor evaluation in the field of R&D projects of antagonists used to interfere with the interaction of complement C5a and its receptor for the treatment of inflammatory diseases as of October 2010. The molecules used to antagonize the interaction of C5a with C5aR include antibodies, proteins, peptides, nucleic acid macromolecules such as aptamers, vaccines and small molecules. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of current active projects in research and development of C5a and C5aR antagonists. In addition, the report lists company-specific pipelines of C5a and C5aR antagonists. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
Index
  • C5 Antagonists
  • C5a Antagonists
  • C5aR Antagonists
  • Corporate C5a & C5aR Antagonist R&D Pipelines
  • About La Merie


More Publications